Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 13/20 | 0.48 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.45 |
| ▸ | THRA | P10827 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27195714 | 1.00 | TRPV1 (0.48) | TRPV1ROCK1KDM4EALDH1A1MAPT | |
| SCHEMBL30806906 | 0.84 | TRPV1 (0.51) | TRPV1ROCK1KDM4EALDH1A1MAPT | |
| SCHEMBL27195733 | 0.82 | TRPV1 (0.59) | TRPV1ROCK1KDM4EALDH1A1MAPT | |
| SCHEMBL13763276 | 0.78 | NPY5R (0.57) | TRPV1KDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL27195785 | 0.77 | LMNA (0.46) | TRPV1 | |
| SCHEMBL11730609 | 0.75 | LMNA (0.65) | TRPV1KDM4EALDH1A1MAPTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL30863454 | 0.75 | CACNA1H (0.43) | KDM4ESMN1; SMN2 | |
| SCHEMBL27195708 | 0.75 | CACNA1H (0.51) | TRPV1ROCK1SMN1; SMN2 | |
| SCHEMBL13544756 | 0.74 | TRPV1 (0.74) | TRPV1NPY5R | |
| SCHEMBL13763268 | 0.74 | TRPV1 (0.56) | TRPV1KDM4EALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | disclosed |